Haploidentical bone marrow transplantation in Mexico

被引:2
|
作者
Eugenio Vazquez-Meraz, Jose [2 ]
Arellano-Galindo, Jose [1 ,3 ]
Mendoza-Garcia, Emma [4 ]
Jimenez-Hernandez, Elva [5 ]
Martinez Avalos, Armando [6 ]
Velazquez Guadarrama, Norma [7 ]
Mejia Arangure, Juan Manuel [8 ]
机构
[1] Hosp Infantil Mexico Dr Federico Gomez, Dept Hematol, Lab Invest Hematol, Mexico City 06720, DF, Mexico
[2] Hosp Gen Ecatepec, Banco Sangre, Las Americas, Ecatepec Estado, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Virol Lab, Mexico City 06720, DF, Mexico
[4] Hosp Gen Mexico City, Hematol Lab, Mexico City, DF, Mexico
[5] Especialidad Ctr Med Nacl Raza IMSS, Dept Hematol, Pediat Unidad Med Alta, Mexico City, DF, Mexico
[6] Inst Nacl Pediat, Dept Oncol, Mexico City, DF, Mexico
[7] Hosp Infantil Mexico Dr Federico Gomez, Bacteriol Lab, Mexico City 06720, DF, Mexico
[8] Ctr Med Nacl Siglo XXI IMSS, Mexico City, DF, Mexico
关键词
chronic myelocytic leukemia; CliniMACS; haploidentical hematopoyetic stem cell transplantation; lymphocytic leukemia; STEM-CELL TRANSPLANTATION; PEDIATRIC LEUKEMIA; UNRELATED DONORS; CD34(+) CELLS; CHILDREN;
D O I
10.1002/pbc.24114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Haploidentical hematopoietic cell transplantation using CD34+ cells depleted of T lymphocytes by the CliniMACS is a treatment for hematological malignancy. We report on four Mexican children, three with acute lymphocytic leukemia and one with chronic myelocytic leukemia, who was transplanted with 12 x 106?CD34+?stem cells/kg body weight (98% of purity) with a follow-up of $9{\textstyle{{1} \over {2}}}$ years. The engraftment was successful in three of the four children. All showed cytomegalovirus reactivation, and one died because of graft rejection and infectious complication. The risk of infections was a major problem. Pediatr Blood Cancer 2012; 59: 950952. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:950 / 952
页数:3
相关论文
共 50 条
  • [41] T-cell replete haploidentical bone marrow transplantation and post-transplant cyclophosphamide for patients with inborn errors
    Kurzay, Mathias
    Hauck, Fabian
    Schmid, Irene
    Wiebking, Volker
    Eichinger, Anna
    Jung, Eva
    Boekstegers, Ann
    Feuchtinger, Tobias
    Klein, Christoph
    Albert, Michael H.
    HAEMATOLOGICA, 2019, 104 (10) : E478 - E482
  • [42] Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow Transplantation
    Katsanis, Emmanuel
    Stea, Baldassarre
    Kovacs, Kristen
    Truscott, Laurel
    Husnain, Muhammad
    Khurana, Sharad
    Roe, Denise J.
    Simpson, Richard J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 390.e1 - 390.e10
  • [43] Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies
    Klein, Orly R.
    Buddenbaum, Jessica
    Tucker, Noah
    Chen, Allen R.
    Gamper, Christopher J.
    Loeb, David
    Zambidis, Elias
    Llosa, Nicolas J.
    Huo, Jeffrey S.
    Robey, Nancy
    Holuba, Mary Jo
    Kasamon, Yvette L.
    McCurdy, Shannon R.
    Ambinder, Richard
    Bolanos-Meade, Javier
    Luznik, Leo
    Fuchs, Ephraim J.
    Jones, Richard J.
    Cooke, Kenneth R.
    Symons, Heather J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 325 - 332
  • [44] Case Report: Haploidentical Bone Marrow Transplantation in Two Brothers With Wiskott-Aldrich Syndrome Using Their Father as the Donor
    Smith, Jasmine
    Alfonso, Jessica Hass
    Reddivalla, Naresh
    Angulo, Pablo
    Katsanis, Emmanuel
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [45] Paternal bone marrow infusion as salvage therapy for severe GVHD following maternal haploidentical transplantation resulting in biparental chimerism
    Jaiswal, Sarita Rani
    Chatterjee, Sumita
    Chakrabarti, Suparno
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (04) : 504 - 508
  • [46] Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up
    Raiola, Anna M.
    Di Grazia, Carmen
    Dominietto, Alida
    Bregante, Stefania
    Giammarco, Sabrina
    Varaldo, Riccardo
    Sora, Federica
    Metafuni, Elisabetta
    Limongiello, Maria A.
    Laudisi, Antonella
    Passannante, Monica
    Galli, Eugenio
    Gambella, Massimiliano
    Sica, Simona
    Bacigalupo, Andrea
    Angelucci, Emanuele
    Chiusolo, Patrizia
    BLOOD ADVANCES, 2024, 8 (08) : 1964 - 1967
  • [47] Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
    McCurdy, Shannon R.
    Muth, Stephen T.
    Tsai, Hua-Ling
    Symons, Heather J.
    Huff, Carol Ann
    Matsui, William H.
    Borrello, Ivan
    Gladstone, Douglas E.
    Swinnen, Lode J.
    Cooke, Kenneth R.
    Brodsky, Robert A.
    Bolanos-Meade, Javier
    Ambinder, Richard F.
    Varadhan, Ravi
    Luznik, Leo
    Jones, Richard J.
    Bettinot, Maria P.
    Fuchs, Ephraim J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (10) : 2056 - 2064
  • [48] Successful second bone marrow transplantation in Omenn's syndrome after bone marrow aplasia: A case report
    Wahadneh, Adel
    Bin-Dahman, Haifa
    Habahbeh, Zeyad
    Abu-Shukear, Mohammad
    Ajarmeh, Mohammad
    Zyood, Raed
    Khaled, Ahmad
    PEDIATRIC TRANSPLANTATION, 2012, 16 (02) : E43 - E48
  • [49] Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia
    Paul, Suman
    Tsai, Hua-Ling
    Lowery, Patrick
    Fuchs, Ephraim J.
    Luznik, Leo
    Bolanos-Meade, Javier
    Swinnen, Lode J.
    Shanbhag, Satish
    Wagner-Johnston, Nina
    Varadhan, Ravi
    Ambinder, Richard F.
    Jones, Richard J.
    Gladstone, Douglas E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : 502 - 508
  • [50] T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies
    Katsanis, Emmanuel
    Sapp, Lauren N.
    Reid, Susie Cienfuegos
    Reddivalla, Naresh
    Stea, Baldassarre
    FRONTIERS IN PEDIATRICS, 2020, 8